MR编号 | AT/H/0126/001 |
---|
药品名称 | FSME-Immun 0,25 ml Junior |
---|
活性成分 | - Tick-borne-encephalitis virus, inactivated 1.2 µg
|
---|
剂型 | Suspension for injection |
---|
上市许可持有人 | Pfizer Corporation Austria Gesellschaft m.b.H.
Floridsdorfer Hauptstraße 1
1210 Wien |
---|
参考成员国 - 产品名称 | Austria (AT) FSME-Immun 0,25 ml Junior Injektionssuspension in einer Fertigspritze |
---|
互认成员国 - 产品名称 | - Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- France (FR)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
TicoVac 1,2µg/dozėje injekcinė suspensija užpildytame švirkšte - Estonia (EE)
- Hungary (HU)
- Czechia (CZ)
- Slovakia (SK)
- Slovenia (SI)
- Greece (GR)
- Bulgaria (BG)
- Romania (RO)
- Cyprus (CY)
Ticovac Junior 0.25ml suspension for injection in a prefilled syringe - Croatia (HR)
- Malta (MT)
|
---|
许可日期 | 2003/06/06 |
---|
最近更新日期 | 2025/02/03 |
---|
药物ATC编码 | - J07BA01 encephalitis, tick borne, inactivated, whole virus
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Article 4.8 Di 65/65
- TypeLevel4:Biological: Vaccine
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|